Navigation Links
Nanobiotechnology experts join forces to improve TB testing

Two UK companies have been awarded joint funding for a research project that could see significant advances in the quest to aid detection and eradication of Tuberculosis (TB), across the world.

The National Physical Laboratory (NPL) and Orla Protein Technologies (Orla) have been awarded 91,000 by the Technology Strategy Board to investigate improved methods for the detection of TB.

The project, which begins in this month, involves a combination of cutting edge technologies and expertise based here in the UK, including areas of molecular and biological diagnostics (Orla), and measurement science and infectious diseases (NPL).

Mycobacterium tuberculosis (MTB) is a pathogenic bacterial species in the genus Mycobacterium and the causative agent of almost all cases if tuberculosis.

More than five thousand people die every day from TB, largely in the developing world. TB is one of the major lethal factors among AIDS patients. Largely, TB affects the developing world where the situation is worsened with the infection becoming one of the main lethal factors among HIV-infected individuals.

Current methods of TB detection suffer from a need for large sample volumes, long preparation times and different results from different patient groups. This has led to a demand for more sensitive and rapid approaches to be developed.

The Consortium aims to meet this demand, by producing systems which dramatically advance current methods; helping to improve the sensitivity, specificity, cost and speed of results.

Max Ryadnov, Project Leader at NPL, said: "The main objective of the project is to demonstrate the possibility of detecting MTB quickly and cost effectively in both clinical and near-patient settings. Such capability is a Holy Grail of modern diagnostics of MTB and would significantly impact on the UK and global healthcare markets."

The study will make use of techniques developed at the National Physical Laboratory for the detection of MTB antigens - biomarkers which indicate disease to rapidly assess the presence of the MTB in a sample. These techniques are empowered by a unique technology developed by Orla PT allowing the fabrication of protein patterned surfaces responsive to MTB biomarkers thereby making the manufacture and use of biomarker detection dramatically simpler"

Dale Athey, Chief Executive at Orla, said: "The development of such procedures will help to substantially improve health systems in resource-limiting settings, particularly in HIV-infected TB cases, where sensitivity remains well below confidence limits for all MTB tests.

"We hope the project will allow us to significantly improve consistency and enhanced sensitivity for cost-effective, easy to use point-of-care-solutions for the detection and eradication of MTB."

The project team will also work closely with colleagues in the Health Protection Agency for advice on microbiology, and to arrange testing in a clinical environment.


Contact: David Lewis
National Physical Laboratory

Related biology technology :

1. Global Nanobiotechnology Market to Reach $4.94 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
2. SU research team uses nanobiotechnology-manipulated light particles to accelerate algae growth
3. USP's 2008 Annual Scientific Meeting to Convene Scientific Experts from Around the World
4. Celebrity Designer Ty Pennington to Host 10th Annual ADHD Experts on Call Program
5. Health Experts Call for New Strategies to Combat Alarming Rise in Diabetes
6. Genstruct Added to The Biomarker Consortiums Rapidly Growing Roster of Industry Experts
7. MaxCyte Hosts Live Discussion with Industry Experts on the Challenges in Developing Cell-Based Screening Assays for Drug Discovery
8. BioFlorida Selects Collexis as the Primary Professional Network for its 200 Member Companies and Organizations
9. Top LASIK and Refractive Experts in Trusted LASIK Surgeons Directory Present Research and Educate Their Peers at Annual AAO Meeting in Atlanta
10. Experts argue nano food-additives require new oversight
11. African Ancestry, Educators, Identity Experts Launch DNA Education Project during Historic Black History Month; 7th Graders Score High on Ultimate Self Test
Post Your Comments:
(Date:11/27/2015)... 27, 2015 /PRNewswire/--  Mallinckrodt plc (NYSE: MNK ... it has closed the sale of its global contrast ... NYSE Euronext) in a transaction valued at approximately $270 ... and a total of approximately 1,000 employees spread across ... St. Louis area. This entire workforce and ...
(Date:11/27/2015)... , November 27, 2015 ... Growing popularity of companion diagnostics is ... cancer biomarkers market with pharmaceutical companies and ... companion diagnostic tests. . ... Complete report on global cancer biomarkers ...
(Date:11/26/2015)... England , November 26, 2015 ... innovative medical device company specializing in imaging technologies, announced today ... European Commission as part of the Horizon 2020 European Union ... carry out a large-scale clinical trial in breast cancer. ... (Logo: , --> --> ...
(Date:11/25/2015)... ANNAPOLIS, Md. , Nov. 25, 2015  PharmAthene, ... of Directors has adopted a stockholder rights plan (Rights ... its net operating loss carryforwards (NOLs) under Section 382 ... --> --> PharmAthene,s use of its ... an "ownership change" as defined in Section 382 of ...
Breaking Biology Technology:
(Date:11/9/2015)... Calif. , Nov. 9, 2015  Synaptics Inc. ... interface solutions, today announced broader entry into the automotive ... solutions that match the pace of consumer electronics human ... biometric sensors are ideal for the automotive industry and ... Europe , ...
(Date:10/29/2015)... Oct. 29, 2015   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce that ... Association (MHTA) as one of only three finalists for ... – Small and Growing" category. The Tekne Awards honor ... shown superior technology innovation and leadership. ...
(Date:10/29/2015)... 2015  Rubicon Genomics, Inc., today announced an ... its DNA library preparation products, including the ThruPLEX ... Plasma-seq kit. ThruPLEX Plasma-seq has been optimized for ... libraries for liquid biopsies--the analysis of cell-free circulating ... in cancer and other conditions. Eurofins Scientific is ...
Breaking Biology News(10 mins):